Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AQNB - US0158578080

25.645 USD
+0.09 (+0.37%)
Last: 12/22/2025, 8:04:00 PM
25.53 USD
-0.11 (-0.45%)
After Hours: 12/15/2025, 8:05:27 PM
Fundamental Rating

3

Taking everything into account, AQNB scores 3 out of 10 in our fundamental rating. AQNB was compared to 26 industry peers in the Multi-Utilities industry. AQNB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AQNB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AQNB had positive earnings in the past year.
In the past year AQNB had a positive cash flow from operations.
In multiple years AQNB reported negative net income over the last 5 years.
Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

AQNB has a worse Return On Assets (-0.27%) than 96.15% of its industry peers.
With a Return On Equity value of -0.80%, AQNB is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
AQNB has a worse Return On Invested Capital (3.16%) than 88.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AQNB is in line with the industry average of 3.94%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Operating Margin value of 21.55%, AQNB perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
In the last couple of years the Operating Margin of AQNB has declined.
AQNB has a better Gross Margin (73.94%) than 73.08% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
The number of shares outstanding for AQNB has been increased compared to 1 year ago.
AQNB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AQNB has an improved debt to assets ratio.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AQNB has an Altman-Z score of 1.31. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.31, AQNB belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
A Debt/Equity ratio of 1.33 is on the high side and indicates that AQNB has dependencies on debt financing.
With a decent Debt to Equity ratio value of 1.33, AQNB is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.46
WACC6.89%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.23 indicates that AQNB should not have too much problems paying its short term obligations.
AQNB has a better Current ratio (1.23) than 88.46% of its industry peers.
AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AQNB (1.03) is better than 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.79%.
The earnings per share for AQNB have been decreasing by -10.38% on average. This is quite bad
AQNB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.92%.
Measured over the past years, AQNB shows a small growth in Revenue. The Revenue has been growing by 7.38% on average per year.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%

3.2 Future

Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 4.09% on average per year.
The Revenue is expected to grow by 2.30% on average over the next years.
EPS Next Y-12.26%
EPS Next 2Y-0.67%
EPS Next 3Y6.57%
EPS Next 5Y4.09%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 77.71, the valuation of AQNB can be described as expensive.
Based on the Price/Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.61, AQNB is valued quite expensively.
A Price/Forward Earnings ratio of 70.25 indicates a quite expensive valuation of AQNB.
Based on the Price/Forward Earnings ratio, AQNB is valued expensively inside the industry as 96.15% of the companies are valued cheaper.
AQNB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.01.
Industry RankSector Rank
PE 77.71
Fwd PE 70.25
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AQNB's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.54
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.67%
EPS Next 3Y6.57%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.21%, AQNB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.56, AQNB pays a better dividend. On top of this AQNB pays more dividend than 88.46% of the companies listed in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 4.21%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AQNB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-569.86%
EPS Next 2Y-0.67%
EPS Next 3Y6.57%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079

NYSE:AQNB (12/22/2025, 8:04:00 PM)

After market: 25.53 -0.11 (-0.45%)

25.645

+0.09 (+0.37%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners74.44%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.70B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts68.33
Price Target22.06 (-13.98%)
Short Float %0%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 4.21%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date09-15 2025-09-15 (0.5412)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)11.44%
PT rev (3m)-1.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.05%
EPS NY rev (1m)3.27%
EPS NY rev (3m)3.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.47%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)1.72%
Valuation
Industry RankSector Rank
PE 77.71
Fwd PE 70.25
P/S 8.25
P/FCF N/A
P/OCF 42.3
P/B 4.24
P/tB 6.04
EV/EBITDA 28.54
EPS(TTM)0.33
EY1.29%
EPS(NY)0.37
Fwd EY1.42%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.36%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.31
F-Score4
WACC6.89%
ROIC/WACC0.46
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-12.26%
EPS Next 2Y-0.67%
EPS Next 3Y6.57%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year46.43%
EBIT Next 3Y20.94%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status for AQNB stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for AQNB stock?

The Earnings per Share (EPS) of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) is expected to decline by -12.26% in the next year.


How sustainable is the dividend of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.